back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-15 18:11 Tx date 2024-04-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,360
-800 vol $10.45 each |
49,278 | |
| Filed 2024-04-15 18:10 Tx date 2024-04-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+1,389 vol $3.60 each |
50,078 | |
| Filed 2024-04-15 18:09 Tx date 2024-04-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-5,000.40
-1,389 vol $3.60 each |
200,679 | |
| Filed 2024-03-29 16:54 Tx date 2024-03-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,190.58
-2,114 vol $10.97 each |
48,689 | |
| Filed 2024-03-29 16:53 Tx date 2024-03-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,999
+4,329 vol $2.31 each |
50,803 | |
| Filed 2024-03-29 16:52 Tx date 2024-03-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-9,999.99
-4,329 vol $2.31 each |
202,068 | |
| Filed 2023-12-29 12:46 Tx date 2023-12-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,151
-1,390 vol $10.90 each |
46,474 | |
| Filed 2023-12-29 12:45 Tx date 2023-12-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,998
+3,144 vol $1.59 each |
47,864 | |
| Filed 2023-12-29 12:44 Tx date 2023-12-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-4,998.96
-3,144 vol $1.59 each |
206,397 | |
| Filed 2023-11-27 14:15 Tx date 2023-11-24 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,219.25
-269 vol $8.25 each |
44,720 | |
| Filed 2023-08-22 17:29 Tx date 2023-08-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,283.05
-673 vol $7.85 each |
44,989 | |
| Filed 2023-07-24 17:03 Tx date 2023-07-24 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,523.32
-6,796 vol $8.17 each |
45,662 | |
| Filed 2023-07-24 17:01 Tx date 2023-07-24 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,999
+16,666 vol $0.72 each |
52,458 | |
| Filed 2023-07-24 17:00 Tx date 2023-07-24 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-11,999.52
-16,666 vol $0.72 each |
209,541 | |
| Filed 2023-07-06 17:28 Tx date 2023-07-06 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-18,693.29
-2,207 vol $8.47 each |
35,792 | |
| Filed 2023-07-06 17:27 Tx date 2023-07-06 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,999
+5,208 vol $0.96 each |
37,999 | |
| Filed 2023-07-06 17:25 Tx date 2023-07-06 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,999.68
-5,208 vol $0.96 each |
226,207 | |
| Filed 2023-07-06 17:23 Tx date 2023-07-06 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-4,999.68
-5,208 vol $0.96 each |
||
| Filed 2023-06-13 10:29 Tx date 2023-06-12 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$175,600
+20,000 vol $8.78 each |
231,415 | |
| Filed 2023-04-28 16:54 Tx date 2023-04-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,639.44
-916 vol $8.34 each |
32,791 | |
| Filed 2023-04-28 16:52 Tx date 2023-04-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,998
+1,700 vol $2.94 each |
33,707 | |
| Filed 2023-04-28 16:49 Tx date 2023-04-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,998
-1,700 vol $2.94 each |
211,415 | |
| Filed 2023-03-03 17:29 Tx date 2023-03-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,788.93
-2,177 vol $9.09 each |
32,007 | |
| Filed 2023-03-03 17:28 Tx date 2023-03-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+4,166 vol |
34,184 | |
| Filed 2023-03-03 17:26 Tx date 2023-03-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
+4,166 vol |
||
| Filed 2023-03-03 17:24 Tx date 2023-03-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,998.40
-4,166 vol $2.40 each |
213,115 | |
| Filed 2023-03-03 17:22 Tx date 2023-03-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
+4,166 vol |
||
| Filed 2023-03-03 17:20 Tx date 2023-03-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$9,998
+4,166 vol $2.40 each |
||
| Filed 2022-11-17 15:30 Tx date 2022-11-17 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,660.67
-333 vol $7.99 each |
30,018 | |
| Filed 2022-10-20 17:23 Tx date 2022-10-20 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+4,762 vol |
30,351 | |
| Filed 2022-10-20 17:22 Tx date 2022-10-20 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,081.68
-2,068 vol $8.26 each |
25,589 | |
| Filed 2022-10-20 17:18 Tx date 2022-10-20 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-5,000.10
-4,762 vol $1.05 each |
217,281 | |
| Filed 2022-07-18 17:45 Tx date 2022-07-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,339.30
-4,379 vol $6.70 each |
27,657 | |
| Filed 2022-07-18 17:43 Tx date 2022-07-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,999
+11,111 vol $0.45 each |
32,036 | |
| Filed 2022-07-18 17:39 Tx date 2022-07-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$4,999
+11,111 vol $0.45 each |
222,043 | |
| Filed 2022-06-16 09:45 Tx date 2022-06-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$111,800
+20,000 vol $5.59 each |
210,932 | |
| Filed 2022-03-09 15:53 Tx date 2022-03-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,999
+9,259 vol $0.54 each |
20,925 | |
| Filed 2022-03-09 15:52 Tx date 2022-03-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,999
+8,333 vol $0.60 each |
11,666 | |
| Filed 2022-03-08 11:35 Tx date 2022-03-08 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,999.86
-9,259 vol $0.54 each |
190,932 | |
| Filed 2022-03-08 11:31 Tx date 2022-03-08 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-8,333 vol |
200,191 | |
| Filed 2021-10-28 09:39 Tx date 2021-10-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,999.50
-3,333 vol $1.50 each |
208,524 | |
| Filed 2021-10-28 09:35 Tx date 2021-10-26 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,999
+3,333 vol $1.50 each |
3,333 | |
| Filed 2021-10-28 09:31 Tx date 2011-08-25 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-30 16:45 Tx date 2021-06-29 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,400
+20,000 vol $7.52 each |
211,857 | |
| Filed 2020-08-14 09:03 Tx date 2020-08-13 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,400
+20,000 vol $6.17 each |
191,857 | |
| Filed 2019-06-19 12:55 Tx date 2019-06-18 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,200
+20,000 vol $4.26 each |
171,857 | |
| Filed 2018-06-10 Tx date 2018-06-08 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$218,600
+20,000 vol $10.93 each |
151,857 | |
| Filed 2017-06-28 Tx date 2017-06-27 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+20,000 vol $5.10 each |
131,857 | |
| Filed 2016-06-10 Tx date 2016-06-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,999
+14,344 vol $2.44 each |
111,857 | |
| Filed 2015-11-17 Tx date 2015-11-16 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,996
+4,062 vol $1.23 each |
97,513 | |
| Filed 2015-08-04 Tx date 2015-08-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,998
+2,127 vol $2.35 each |
93,451 | |
| Filed 2015-05-18 Tx date 2015-05-11 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,997
+2,173 vol $2.30 each |
91,324 | |
| Filed 2015-05-18 Tx date 2015-03-16 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,999
+1,992 vol $2.51 each |
89,151 | |
| Filed 2015-05-18 Tx date 2014-12-31 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$26,900
+10,000 vol $2.69 each |
87,159 | |
| Filed 2015-05-18 Tx date 2014-11-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,998
+1,960 vol $2.55 each |
77,159 | |
| Filed 2015-05-18 Tx date 2014-09-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-150,409 vol |
75,199 | |
| Filed 2015-05-18 Tx date 2014-08-04 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,999
+5,376 vol $0.93 each |
225,608 |